RAPA-501 Therapy for ALS

Clinical trial NCT04220190 · RECRUITING

Trial details

NCT number: NCT04220190
Sponsor: Rapa Therapeutics LLC
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2025-01-02
Primary completion: 2026-07-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.